Difference between revisions of "PMS-pathway control state"
(Created page with "{{MitoPedia |abbr=PMS |description=left|200px|GMS'''PMS''': Pyruvate & Malate & Succinate. '''MitoPathway control:''' CI&II Transaminase catalyz...") |
m (Cardoso Luiza moved page PMS to PMS-pathway control state: Edited to have same nomenclature used in other pages) |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{MitoPedia | {{MitoPedia | ||
|abbr=PMS | |abbr=PMS | ||
|description=[[File:PMS.jpg|left|200px| | |description=[[File:PMS.jpg|left|200px|PMS]]'''PMS''': [[Pyruvate]] & [[Malate]] & [[Succinate]]. | ||
'''MitoPathway control:''' CI&II | '''MitoPathway control:''' CI&II | ||
[[Pyruvate]] (P) is oxidatively decarboxylated to acetyl-CoA and CO<sub>2</sub>, yielding [[NADH]] catalyzed by pyruvate dehydrogenase. [[Malate]] (M) is oxidized to oxaloacetate by mt-malate dehydrogenase located in the mitochondrial matrix. Condensation of oxaloacate with acetyl-CoA yields citrate (citrate synthase). This documents an additive effect of convergent CI&II electron flow to the Q-junction, with consistent results obtained with permeabilized muscle fibres and isolated mitochondria (Gnaiger 2009). | |||
|info=[[Gnaiger | |info=[[Gnaiger 2020 BEC MitoPathways]] | ||
[[File:PMS.jpg|right|400px|PMS]] | |||
}} | }} | ||
::: ''More details'' | ::: ''More details'' | ||
::::» [[Additive effect of convergent electron flow]] | ::::» [[Additive effect of convergent electron flow]] | ||
::::» [[Respiratory_complexes#Respiratory_complexes_-_more_than_five |Respiratory complexes - more than five]] | ::::» [[Respiratory_complexes#Respiratory_complexes_-_more_than_five |Respiratory complexes - more than five]] | ||
::::» [[Convergent electron flow]] | ::::» [[Convergent electron flow]] | ||
::::» [[NS-pathway control state]] | ::::» [[NS-pathway control state]] | ||
| Line 31: | Line 25: | ||
:::*[[SUIT-004]] | :::*[[SUIT-004]] | ||
::::* DL-Protocol for permeabilized fibers (pfi): [[SUIT-004 O2 pfi D010]] | ::::* DL-Protocol for permeabilized fibers (pfi): [[SUIT-004 O2 pfi D010]] | ||
{{MitoPedia concepts | |||
|mitopedia concept=SUIT state | |||
}} | |||
Latest revision as of 18:30, 17 March 2022
- high-resolution terminology - matching measurements at high-resolution
PMS-pathway control state
Description
PMS: Pyruvate & Malate & Succinate.
MitoPathway control: CI&II
Pyruvate (P) is oxidatively decarboxylated to acetyl-CoA and CO2, yielding NADH catalyzed by pyruvate dehydrogenase. Malate (M) is oxidized to oxaloacetate by mt-malate dehydrogenase located in the mitochondrial matrix. Condensation of oxaloacate with acetyl-CoA yields citrate (citrate synthase). This documents an additive effect of convergent CI&II electron flow to the Q-junction, with consistent results obtained with permeabilized muscle fibres and isolated mitochondria (Gnaiger 2009).
Abbreviation: PMS
Reference: Gnaiger 2020 BEC MitoPathways
PMSL
PMS pathway in the LEAK state can be evaluated in the following SUIT protocols:
PMSP
PMS pathway in the OXPHOS state can be evaluated in the following SUIT protocols:
PMSE
PMS pathway in the ET state can be evaluated in the following SUIT protocols:
-
- DL-Protocol for permeabilized fibers (pfi): SUIT-004 O2 pfi D010
-
MitoPedia concepts:
SUIT state
